Nwagwu, Chibueze D.
Defensor, Erwin
Jiang, Michael Y.
Rolle-McFarland, Danelle A.
Carbonell, Anne-Marie E. https://orcid.org/0000-0003-2779-9409
Carbonell, W. Shawn https://orcid.org/0000-0001-7829-2152
Funding for this research was provided by:
Vium, Inc. Next Generation Disease Model Grant
Vium, Inc.
Article History
Received: 23 September 2019
Accepted: 8 June 2020
First Online: 20 July 2020
Competing interests
: The authors declare the following competing interests: C.D.N., W.S.C. and M.Y.J. are past employees of OncoSynergy, Inc., the company that developed and owns OS2966. A.-M.E.C. is a current Executive and Shareholder of OncoSynergy, Inc. D.A.R. is a current employee of OncoSynergy, Inc. W.S.C. is a former Director and current Shareholder of OncoSynergy, Inc. E.D. is an employee of Vium, Inc., the corporation that funded this research and designed the Vium digital vivarium monitoring platform used in this study.